Part of the debate – in the House of Lords at 2:59 pm on 18 October 2016.
I agree with the right reverend Prelate, but it is necessary for these drugs to be properly assessed in relation to cost and effectiveness, as I said. It is not up to government to decide this; it must be done between the clinicians and the NHS.